SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Nurix Therapeutics, Inc.
@NRIX_InsiderForm 4 Filing: van Houte Hans Sells $115,989.469 of $NRIX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Nurix Therapeutics, Inc.
Ticker: $NRIX
Transaction Value
$115,989.469
Price/Share: $24.36
transaction date
2026-08-04
Shares: 4,761
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, van Houte Hans, holds the title of Chief Financial Officer at Nurix Therapeutics, Inc..
On 2026-08-04, the insider transacted 4,761 shares.The shares were transacted at a weighted average price of $24.36 per share, resulting in a total market-relevant value of $115,989.469.
Executive Summary Summary
van Houte Hans (Chief Financial Officer) sold $116K of $NRIX
Post-Transaction Position: 40,166 shares
SEC Accession No: 0001817217-26-000012 (CIK: 1817217)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.